12 completed. 12 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 12 |
| Phase 2 | 3 | Completed 3 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease N-803 - Hiv, HIV Infections | Phase 1 | Completed | University of Minnesota | 10 | 2021-04-01 | 2024-04-02 |
| Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults Ad35-GRIN, MVA.HIVconsv, pSG2.HIVconsv DNA - AIDS | Phase 1 / Phase 2 | Completed | University of Oxford | 72 | 2014-03-01 | 2016-05-30 |
| Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Extended-Release Naltrexone - HIV, AIDS | Phase 1 / Phase 2 | Completed | Yale University | 151 | 2011-03-01 | 2020-03-19 |
| Study Targeting Affect Regulation Resilient Affective Processing Therapy (RAPT) - HIV, AIDS | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 56 | 2010-09-01 | 2014-10-27 |
| Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine Blood collection, GSK HIV vaccine 732462 - AIDS | Phase 1 | Completed | GlaxoSmithKline | 190 | 2010-03-22 | 2018-03-02 |
| Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old HIV Vaccine 732462, Placebo vaccine - AIDS | Phase 1 | Completed | GlaxoSmithKline | 41 | 2009-02-03 | 2018-06-18 |
| VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer Efavirenz; Tenofovir disoproxil fumarate; Telaprevir - Hepatitis C, HCV | Phase 1 | Completed | Tibotec BVBA | 20 | 2009-02-01 | 2010-12-17 |
| TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. TMC125 - HIV, AIDS | Phase 1 | Completed | Tibotec Pharmaceuticals, Ireland | 18 | 2008-09-01 | 2011-06-09 |
| TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers. Darunavir - HIV, AIDS | Phase 1 | Completed | Tibotec Pharmaceuticals, Ireland | 21 | 2008-08-01 | 2011-06-09 |
| TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. TMC278 - HIV, AIDS | Phase 1 | Completed | Tibotec Pharmaceuticals, Ireland | 18 | 2008-07-01 | 2010-04-28 |
| TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function. TMC278 - HIV, AIDS | Phase 1 | Completed | Tibotec Pharmaceuticals, Ireland | 32 | 2008-06-01 | 2010-04-28 |
| Study of Enfuvirtide in HIV-Positive Subjects Fuzeon - HIV Infections, AIDS | Phase 1 | Completed | Trimeris | 26 | 2005-06-24 |
Acquired Immunodeficiency Syndrome (12) · HIV Infections (5) · Substance-Related Disorders (2) · Hepatitis C (1) · Mycoses (1) · Opioid-Related Disorders (1) · Wounds and Injuries (1)
Blood-Borne Infections (12) · Communicable Diseases (12) · Genital Diseases (12) · Immune System Diseases (12) · Immunologic Deficiency Syndromes (12) · Infections (12) · Lentivirus Infections (12) · RNA Virus Infections (12) · Retroviridae Infections (12) · Sexually Transmitted Diseases (12) · Sexually Transmitted Diseases, Viral (12) · Slow Virus Diseases (12) · Urogenital Diseases (12) · Virus Diseases (12) · HIV Infections (7)
Rilpivirine (2) · ALT-803 (1) · Blood Specimen Collection (1) · Darunavir (1) · Enfuvirtide (1) · Naltrexone (1) · Tenofovir (1) · efavirenz (1) · etravirine (1) · telaprevir (1) · vivitrol (1)
Tibotec Pharmaceuticals, Ireland (4) · GlaxoSmithKline (2) · Tibotec BVBA (1) · Trimeris (1) · University of California, San Francisco (1) · University of Minnesota (1) · University of Oxford (1) · Yale University (1)
United States (5) · Germany (2) · France (1) · Kenya (1) · Spain (1)
Adam Carrico, PhD (1) · Frederick L Altice (1) · Sandra A Springer, MD (1) · Timothy Schacker, MD (1) · Walter Jaoko (1)
PMID 23400742, PMID 24144472, PMID 24161160, PMID 24674234, PMID 26560326, PMID 29373393, PMID 29606517, PMID 40342086, PMID 40471871
2009 (1), 5UM1AI126611 (1), K02DA032322 (1)